This condition, often classified under ICU-acquired, includes SIM and is characterized by a significant decline in skeletal muscle strength
To ensure temporality between GLP-1 RA use and SUD onset, we established the observation window from January 1, 2005 (the year of initial GLP-1 RA approval) to February 24, 2025, based on the most recent data available from the AoU dataset
Dizziness may result from the drug itself or from its therapeutic effects, including hypoglycaemia, dehydration from gastrointestinal side effects, or reduced caloric intake
PMID: 6 SadeghiHMAdeliICalinaDDoceaAOMousaviTDanialiMet al
Low concentrations produce a faint, almost translucent pink
In 2023, Black adults received only about 12 percent of prescriptions for popular anti-obesity drugs, while 85 percent went to White patients.21 This stark disparity underscores systemic inequities in the healthcare system, from provider bias to financial barriers, that disproportionately affect communities of color
